Katie Maloney, who stars on Bravo’s “Vanderpump Rules,” has announced she is starting a new matte lipstick line with celebrity makeup artist Julie Hewett. Katie stopped by Cheddar’s LA studios to talk with Alyssa Julya Smith about season 6 of the popular show, telling Alyssa there is even more drama than previous seasons. Katie also talked about her beauty and lifestyle blog, “Pucker and Pout,” and using her readers as test cases for her lipstick line. She says she is partnering with Hewett, who is known for on-set movie makeup, because she was drawn to her work in “Pearl Harbor.” The Julie Hewett x Pucker & Pout collaboration will officially launch early 2018. The cast of "Vanderpump Rules," including Stassi Schroeder, Lala Kent, Tom Sandoval, and Scheana Marie, recently gathered at Lisa Vanderpump's popular restaurant, SUR, to support Maloney's newest endeavor. Season 6 of “Vanderpump Rules” currently airs on Bravo.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More